Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9260371 Compositions and methods for modification of biomolecules

Overview Structured Data Issues Contributors Activity

Is a

Date Filed

April 23, 2013

Date of Patent

February 16, 2016

Patent Application Number

13868444

Patent Citations Received

US Patent 12128109 Muscle targeting complexes and formulations for treating dystrophinopathies

0

US Patent 12012460 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

0

US Patent 12018087 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject

0

US Patent 12102687 Muscle targeting complexes and uses thereof for treating myotonic dystrophy

0

US Patent 11759525 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

US Patent 11771776 Muscle targeting complexes and uses thereof for treating dystrophinopathies

US Patent 11786605 Site specific antibody-drug conjugates with peptide-containing linkers

US Patent 11787869 Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness

US Patent 11833217 Muscle targeting complexes and uses thereof for treating dystrophinopathies

0

US Patent 11839660 Anti-transferrin receptor antibody and uses thereof

0

•••

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Primary Examiner

Find more entities like US Patent 9260371 Compositions and methods for modification of biomolecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.